New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – PERNIX THERAPEUTICS HOLDINGS, INC. (0001024126) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – PERNIX THERAPEUTICS HOLDINGS, INC. (0001024126) (Filer)
Filed: 2016-05-11 AccNo: 0001354488-16-007301 Size: 56 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-05-11T08:01:01-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1024126/000135448816007301/0001354488-16-007301-index.htm